Background: Most women with localized breast cancer have a choice between mastectomy and breast conserving surgery (BCS). Aside from clinical factors, this decision may be associated with surgeon and patient characteristics. We investigated the effect of surgeon characteristics on the BCS rate. Methods: We used the Surveillance, Epidemiology, and End Results-Medicare database to identify women Ͼ65 years, diagnosed with stages I-II BC, between 1991 and 2002, and used the Physician Unique Identification Number linked to the American Medical Association Masterfile to obtain information on surgeons. We investigated the association of patient demographic, tumor, and surgeon-related factors with receipt of BCS, using Generalized Estimating Equations to control for clustering. Results: Of 56,768 women with breast cancer, 30,006 (53%) underwent BCS, whereas 26,762 (47%) underwent mastectomy. Between 1991 and 2002, the proportion of patients undergoing BCS increased from 35% to 60%. In a multivariate analysis, patients who received BCS were younger, of higher SES, and had more favorable tumor characteristics. They were also more likely to be black and live in metropolitan areas. Women who underwent BCS were more likely to have surgeons who were female (OR ϭ 1.40; 95% CI: 1.25-1.55), US-trained (OR ϭ 1.12; 95% CI: 1.02-1.22), with a larger patient panel (OR ϭ 1.29; 95% CI: 1.21-1.39), and completed training after 1975 (OR ϭ 1.16; 95% CI: 1.08 -1.25), than surgeons of patients who underwent mastectomy. Conclusions: Surgeon characteristics, such as gender, training, year of graduation, and volume, are small but significant independent predictor of BCS. Efforts to differentiate whether these associations reflect patients' preferences, quality of physician training, surgeon attitudes, physicianpatient communication, or other effects on decision-making are warranted.
R esearch on the determinants of receipt of cancer treatment has mostly focused on patient factors, such as race/ethnicity, geographic location, age, and socioeconomic status. Relatively less research has evaluated the role of the physician/surgeon in cancer treatment decisions and cancer outcomes. Investigators have reported associations between physician characteristics and the receipt of androgen deprivation therapy for prostate cancer, 1 as well as on referral to an oncologist after a diagnosis of colon 2 or lung cancer. 3 Referrals to subspecialists have also been associated with the primary care physician's gender, number of years in practice, practice patient volume, and practice case mix. 4, 5 It is increasingly apparent that patients who are similar with regard to demographic and clinical characteristics may be treated differently depending on the physician they see.
Women with breast cancer often have many treatment decisions to make. The first is usually surgical, and involves the decision to undergo a mastectomy versus breast conservation surgery (BCS) with radiation. Since the introduction of BCS and the demonstration that survival was equivalent between BCS with RT and mastectomy, despite higher local recurrence rates, 6 its use has increased steadily. Current studies indicate that between 40% to 70% of eligible women receive it. [7] [8] [9] Clinical and demographic features, such as patient age, geographic location and tumor aggressiveness can influence BCS use, 8 BCS fees seem to influence use, 10 and patient preferences also play a strong role. 9 Furthermore, some of this is influenced by physician characteristics. Katz et al found that both patient and surgeon characteristics, such as surgical volume, practice setting, surgeon's attitudes toward treatment recommendations, and surgeon demographics, explained a small amount of the variation in mastectomy versus BCS rates among patients with ductal carcinoma in situ and invasive breast cancer, suggesting that similar patients may receive different treatment depending on their surgeon. 11, 12 Others have shown that preoperative consultations with radiation oncologists 13 and medical oncologists can also influence BCS use. 14 We used a large US population-based registry to investigate the independent association between surgeon-related factors, such as gender, location of training (United States vs. foreign), year of graduation, practice volume, and type of practice on the receipt of BCS among a large cohort of women with stages I and II invasive breast cancer after accounting for other known clinical and demographic factors, and accounting for the influence of physician clustering.
PATIENTS AND METHODS

Patient Selection Criteria
We included women, who participated in Medicare and were therefore over 65 years old, diagnosed with stage I or II breast cancer between 1991 and 2002, who underwent breast cancer surgery within 3 months after their date of diagnosis, and who were not members of a health maintenance organization (n ϭ 80,109); members of an health maintenance organization would not generally bill Medicare for services. We excluded women who did not participate in Medicare Parts A and B during the 12 months prior to their diagnosis (n ϭ 8680), women with unknown primary breast surgery (n ϭ 3652), women who had a prior breast cancer or other cancer (n ϭ 8354), or a diagnosis without histologic confirmation (n ϭ 605).
We excluded women whose physician did not have a UPIN number or a primary or secondary specialty (n ϭ 1680). Many patients had several physicians. Patients whose physician did not have a primary or secondary specialty of surgery were excluded (n ϭ 105). For women with 2 physicians in these categories, if both had a specialty on the list, then the one who was defined as the operating physician was selected and, if neither was an operating physician, then the first one listed was used. Patients whose physicians were missing the primary specialty (n ϭ 25) or for whom neither had a specialty in surgery or general practice (n ϭ 21) were excluded. Of 195 women with 3 or more physicians, only those who had a surgical oncologist (n ϭ 21) were included.
Surgeon Characteristics
Surgeon characteristics included as variables in the AMA Masterfile were gender, graduation year, primary employment setting (private practice vs. other), patient volume, location of training (United States vs. other), and type of degree (Medical Degree ͓MD͔ or Doctor of Osteopathy ͓DO͔). We categorized physician age by year of medical graduation (Ͻ1975 or Ն1975). Over 85% of the physicians were in private practice (self-employed solo, 2-physician, group or other); those who were not in private practice were either employed in a medical school, federal, state or government hospital. We categorized physicians by total number of claims each surgeon had for breast cancer-directed surgery between 1991 and 2002, dichotomized as 1 to 10 versus Ն10 subjects. This was chosen because the top 15% of physicians operated on Ͼ10 subjects. This does not include the surgeon's total volume, only the absolute number of patients that met our inclusion criteria.
Measurement of Treatments and Outcomes
We identified and categorized patients with respect to surgery using the Surveillance, Epidemiology, and End Results (SEER)-Medicare databases and ICD-9-CM procedure, CPT-4, HCPCS, and ICD-9-CM V codes, which have been found to capture virtually all breast cancer cases. 15 We categorized patients as having BCS if they had any of the following: segmental mastectomy, lumpectomy, quadrantectomy, excisional biopsy, and partial mastectomy as the last surgical procedure. We categorized patients as having mastectomy if they had any of the following: modified radical, simple, or radical mastectomy as the last surgical procedure before treatment or within 6 months of diagnosis. We calculated the total number of surgical procedures (biopsies/excisions) within 6 months of diagnosis date.
Socioeconomic Status
We generated an aggregate SES score based on zip code from education, poverty and income data from the 2000 census, following the method adapted by Du et al 16 Patients were ranked on a 1 to 5 scale, where 1 was the lowest value, based on a formula incorporating these variables weighted equally. The 394 patients with missing data were assigned to the lowest SES category. The results did not change if they were assigned a separate category.
Comorbid Disease
To assess the prevalence of comorbid disease in our cohort, we used Klabunde et al adaptation of the Charlson comorbidity index. 17 Medicare inpatient and outpatient claims were searched for ICD-9-CM diagnostic codes in the Medicare files from 12 months before to 1 month after the diagnosis of cancer. Each condition was weighted, and patients were assigned a score based on the Klabunde-Charlson index. 17
Statistical Analysis
The 2 test was used to compare surgeon-related, demographic, and clinical characteristics between patients who received BCS and those who received mastectomy, and between patients who were operated on by a female or by a male surgeon. All hypothesis tests were 2-sided.
The Generalized Estimating Equations (GEE) methodology was introduced by Liang and Zeger 40 to deal with clustering in data that otherwise would be analyzed by means of a generalized linear model. GEEs (PROC GENMOD in SAS) have become an important strategy in the analysis of correlated data. 18 We used GEEs to account for the correlation of outcome measures among patients who had the same physician. The unit of analysis was the patient. For each patient, the physician's unique UPIN number was used as the clustering variable.
We evaluated the odds of BCS for all the categories of each variable, controlling for all other variables in the model and year of diagnosis; the model included: (1) operating physician characteristics (gender, type of degree, country of training, practice type, year of graduation, surgical volume); (2) demographic variables (age, race, marital status, SES); and (3) clinical variables (tumor grade, AJCC stage, receptor status, comorbidity). To evaluate for changes over time, we performed a separate analysis for patients diagnosed from 1991 to 1999 and from 2000 to 2002. We also performed the same analysis for the odds of BCS followed by radiation therapy. Statistical analyses were conducted using the SAS Version 9.13.
RESULTS
We identified 56,768 women in SEER-Medicare who were diagnosed with stages I and II breast cancer, between January 1, 1991 and December 31, 2002, met our eligibility criteria for this study; these women were operated on by 6224 surgeons. Among these women, 30,006 (53%) underwent BCS, and 26,762 (47%) underwent mastectomy. Women who underwent mastectomy had more surgical procedures (biopsies/excisions) than women who underwent BCS. The surgeons who performed BCS in this cohort were predominantly male (89%); in private practice (80%); trained in the United States (80%), and holders of a medical degree (MD) (96%) as opposed to an osteopathic degree (DO) (4%) ( Table 1) . The proportion of women who underwent BCS as opposed to mastectomy increased over the 12 years of our study, but stabilized after 1999. Although the proportion of DOs (vs. MDs) and foreigntrained physicians remained stable at 4% and 16%, respectively, the proportion of surgeries performed by female surgeons increased from 7% in 1991 to 24% in 2002. In addition, female surgeons were more likely to be trained in the United States, perform fewer surgeries per diagnosis, and were less likely to be employed in private practice. Table 2 compares patients who did and did not receive BCS by the characteristics of their surgeons as well as their own demographic and clinical characteristics. BCS was associated with all the clinical, demographic, and physician variables studied, except for type of practice in which the operating surgeon was employed. Specifically, in unadjusted analyses, patients who received BCS were significantly more likely than those who did not to have a surgeon who was female (66% vs. 51%; OR ϭ 1.88), had an M.D. degree (53% vs. 45%; OR ϭ 1.37), was US-trained (54% vs. 47%; OR ϭ 1.30), graduated after 1975 (57% vs. 49%; OR ϭ 1.34) or had performed procedures on Ͼ10 subjects in the cohort (56% vs. 44%; OR ϭ 1.43). Female surgeons were more likely than male surgeons to have patients who resided in a metropolitan location, were married, received chemotherapy, and had fewer comorbid conditions. They were also more likely to have MD degrees, to be US-trained, and to perform more BCS procedures. They were less likely to practice in a private setting.
The multivariate analysis using GEE is shown in Table 3 . Controlling for all other factors, patients who received BCS were more likely than patients who had mastectomy to have their BCS performed by a surgeon who was female (OR ϭ 1.40, 95% CI: 1.25-1.55), US-trained (OR ϭ 1.12, 95% CI: 1.02-1.22), graduated 1975 or later (OR ϭ 1.16, 95% CI: 1.08 -1.24), and who had performed procedures on Ͼ10 subjects in this cohort (OR ϭ 1.29, 95% CI: 1.21-1.38). In contrast, patients who received mastectomy were more likely than those who did not to be older, to have stage II rather than stage I disease, to have more biopsies/excisions, to have Ն1 comorbid conditions, to reside in a metropolitan area, and to be white. The odds of receiving BCS in women diagnosed in 2002 was Ͼ2.5 fold higher that those who were diagnosed in 1991. Interestingly, socioeconomic status was linearly related to receipt of BCS, with those in the highest SES quintile being 34% more likely to undergo BCS (P Ͻ 0.001). The association between physician characteristics and BCS was similar in the early-and late-time intervals.
To control for the interaction between year of diagnosis and surgeon gender, we conducted separate GEE analyses of the association between surgeon gender and receipt of BCS, among patients stratified into 2 groups by year of diagnosis (1991-1999 and 2000 -2002) [ Table 4 ]. Surgeon gender was similarly associated with BCS in both time cohorts.
The analysis was also performed including only the 22,030 women with BCS who had radiation therapy following surgery. In this analysis, black race was not associated with receipt of BCS (OR ϭ 1.09, 95% CI: 0.98 -1.21), suggesting that black women are more likely than white women to get BCS without RT than mastectomy, an indicator of poorer quality care. In this analysis as well, patients of female physicians were 42% more likely to have BCS followed by radiation than patients of male surgeons (P Ͻ 0.0001).
DISCUSSION
In this population-based study of over 50,000 elderly women with stage I/II breast cancer, we found that the number of women undergoing BCS rose from 34% to 55% between 1991 and 1997, and since then has been fairly constant at a rate of 60%. Surgeon characteristics, such as gender, location of medical training, year of graduation, and surgical volume, were independently associated with receipt of BCS. In addition, our study confirmed that patients with poorer prognosis tumors, advanced age, lower socioeconomic status, and those who were unmarried, were less likely than others to undergo BCS, despite the fact that studies have shown that over 70% of patients with stage II tumors can successfully undergo BCS. 19, 20 Although BCS rates have gone up over time, one concerning finding has been that the omission of both radiation following BCS and axillary node dissection have also gone up, suggesting that those with BCS may be more likely to get "inappropriate care." 21 Our group has shown that physician factors, such as surgeon gender, location of training, and type of medical degree influence post BCS radiation. 22 Others have shown that surgeon training and academic affiliation also influence the quality and degree of axillary node dissection. 23, 24 Patient preference has a strong influence on BCS rate. However, patient preference is often influenced by numerous factors, including the information provided by physicians. It was originally thought that the rates of BCS did not increase to higher levels because the eligibility criteria for BCS were not well understood or communicated well to patients; hence, patients may believe that more extensive surgery has greater survival benefits. 20 However, studies have shown that numerous other factors go into this decision Annals of Surgery • Volume 249, Number 5, May 2009 Use of Breast Conservation Surgery in Women making. For example, women who have a consultation with a medical oncologist before surgery are more likely to undergo definitive surgery and axillary node dissection. 14 Also, women seen by general surgeons as opposed to surgical oncologists are less likely to have reconstruction discussed during the decision-making process, which may impact the treatment choice, 25 and women who participate in the surgeon selection process are more likely to be treated by more experienced surgeons. 26 While we know that patient-surgeon communication practices influence women's perceptions of their decision making, 27 this increasing involvement in the decision making process by patients does not necessarily translate into increased use of BCS. 28 We, as have others, 12 found that surgeon procedure volume, as represented by the number of patients the surgeon operated on in this cohort, was associated with receipt of BCS. Other studies have also shown that surgeon procedure volume and subspecialty training are associated with treatment patterns, morbidity, and mortality. 29 While the majority of women in our sample were treated by physicians trained in the United States, those who were not had a higher odds of receiving a mastectomy. Despite the fact that 25% of physicians in the United States are foreign trained, little is known regarding their clinical behavior and outcomes relative to US-trained physicians. The literature evaluating the performance of Doctors of Osteopathy relative to M.D's is also limited. Our group found that, to a lesser degree, these surgeon characteristics were also associated with the receipt of postlumpectomy adjuvant radiation therapy in women with early stage breast cancer. 22 Although all the patients in the cohort were Medicare beneficiaries and therefore had access to care, patient socioeconomic status was also associated with receipt of BCS; women in the highest SES quintile were 25% more likely to undergo BCS than women in the lowest quintile. SES also influences cancer screening, 30 quality of adjuvant breast cancer chemotherapy as measured by intentionally reduced first cycle dose levels, 31 and breast cancer mortality. 32 The reasons for this disparity are not known.
We found the association of surgeon gender and receipt of BCS of interest. Studies report that female patients have a preference for physicians of their own gender 33, 34 ; this preference is stronger when the health concern is gender-related. 35, 36 Women seen by a female physician are more likely to undergo screening with Pap smears and mammograms than those seen by a male physician, particularly if the physician is a family practitioner. 37 Female physicians are more likely to engage patients in discussions that are critical to the establishment of a therapeutic relationship. 38 With regard to breast cancer, 1 small study in women with early-stage breast cancer also suggests that patients seen by female surgeons are more likely to receive BCS than mastectomy. 39 We recognize that the number of female physicians has increased over time, however, we saw a similar effect size for the association between physician gender and odds of BCS in the earlier years as opposed to later years of this analysis.
The SEER-Medicare dataset that we analyzed has the virtue of being population-based, and therefore over 95% of patients are captured without concern for selection bias. Furthermore, unlike some of the studies previously described, a large number of patients in our cohort allow us to adequately control for the multiple confounding variables that influence these associations, as well as control for the influence of physician clustering in a hierarchical model.
The dataset, however, has limitations. It does not include data on a number of variables that might have also been associated with receipt of mastectomy, such as patient choice, psychologic outlook, communication with the physician, or health behaviors and specific contraindications to BCS, such as positive margins, ratio of tumor size to breast size, and presence of multicentric disease. The AMA data lack some detail on practices that have academic affiliations. In addition, our study was limited to patients over the age of 65; it may, therefore, not be generalizable to younger populations. Although these factors may influence the overall rate of BCS, they are not likely to largely influence the association of BCS with the physician characteristics that we observed.
Our study demonstrates a small but independent association between certain specific surgeon characteristics and the choice of surgical treatment of localized breast cancer. While we don't advocate choosing a surgeon based on gender, we do recognize that differences in communication styles and surgeon preferences may influence patient choice when the decisions are complex. Efforts aimed at understanding how specific physician characteristics may influence treatment variability for all aspects of breast cancer care are warranted. A better understanding of whether these differences stem from physician training, communication styles or other factors may result in interventions to improve cancer care.
